AstraZeneca, Pozen Sue Lupin To Block Generic Vimovo
AstraZeneca AB and Pozen Inc. sued India-based Lupin Ltd. in New Jersey federal court Monday in an effort to protect the market for the arthritis drug Vimovo....To view the full article, register now.
Already a subscriber? Click here to view full article